• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续静脉输注柔红霉素在治疗急性非淋巴细胞白血病方面有效。

Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia.

作者信息

Lewis J P, Meyers F J, Tanaka L

出版信息

Br J Haematol. 1985 Oct;61(2):261-5. doi: 10.1111/j.1365-2141.1985.tb02824.x.

DOI:10.1111/j.1365-2141.1985.tb02824.x
PMID:4041369
Abstract

Anthracyclines given by continuous infusion, as opposed to bolus administration, are associated with a reduced incidence of cardiac and gastrointestinal toxicity. Our study was developed to test the antileukaemic effect of anthracyclines given as a continuous infusion. Nineteen sequential patients admitted for treatment of acute nonlymphocytic leukaemia (ANLL) were managed with a regimen utilizing a 3 d continuous intravenous infusion of daunomycin (DNM), and the complete response rate was similar to this institution's past experience with antileukaemic regimens employing 3 d bolus DNM. In our studies, infusion DNM was at least as myelotoxic and antileukaemic as bolus DNM; thus this method of administration should be explored further in remission-induction regimens for ANLL.

摘要

与大剂量推注给药相比,持续输注蒽环类药物可降低心脏和胃肠道毒性的发生率。我们开展这项研究旨在测试持续输注蒽环类药物的抗白血病效果。19例连续收治的急性非淋巴细胞白血病(ANLL)患者采用了柔红霉素(DNM)持续静脉输注3天的方案进行治疗,完全缓解率与本机构过去使用大剂量推注DNM的抗白血病方案的经验相似。在我们的研究中,输注DNM的骨髓毒性和抗白血病作用至少与推注DNM相同;因此,这种给药方法应在ANLL的缓解诱导方案中进一步探索。

相似文献

1
Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia.持续静脉输注柔红霉素在治疗急性非淋巴细胞白血病方面有效。
Br J Haematol. 1985 Oct;61(2):261-5. doi: 10.1111/j.1365-2141.1985.tb02824.x.
2
Remission-induction regimens in acute nonlymphocytic leukemia.急性非淋巴细胞白血病的诱导缓解方案。
West J Med. 1980 Oct;133(4):279-88.
3
A randomized study of mitoxantrone plus cytarabine versus daunomycin plus cytarabine in the treatment of previously untreated adult patients with acute nonlymphocytic leukemia.米托蒽醌联合阿糖胞苷与柔红霉素联合阿糖胞苷治疗初治成年急性非淋巴细胞白血病患者的随机研究。
Ann Hematol. 1994 Jul;69(1):11-5. doi: 10.1007/BF01757342.
4
Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.阿糖胞苷与硫鸟嘌呤联合安吖啶或柔红霉素治疗初治急性非淋巴细胞白血病的比较试验:L-16M方案的结果
Leukemia. 1989 Feb;3(2):115-21.
5
High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.大剂量阿糖胞苷、柔红霉素和6-硫鸟嘌呤用于复发或难治性急性非淋巴细胞白血病的治疗
Oncology. 1987;44(6):333-5. doi: 10.1159/000226506.
6
Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.维持化疗可延长成人急性非淋巴细胞白血病的缓解期。
J Clin Oncol. 1988 Apr;6(4):583-7. doi: 10.1200/JCO.1988.6.4.583.
7
[A regimen of DATV in the treatment of acute nonlymphocytic leukemia with high complete remission rate].[地西他滨联合阿糖胞苷、硫鸟嘌呤及长春新碱方案治疗急性非淋巴细胞白血病,完全缓解率高]
Zhonghua Nei Ke Za Zhi. 1992 Mar;31(3):146-8, 187.
8
Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.成人急性髓细胞白血病的蒽环类药物分次治疗
Cancer Chemother Pharmacol. 1989;23(6):401-2. doi: 10.1007/BF00435846.
9
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).一项针对成人急性淋巴细胞白血病诱导治疗(柔红霉素、长春新碱、泼尼松与柔红霉素、长春新碱、泼尼松、阿糖胞苷和6-硫鸟嘌呤)的随机试验及长期随访:东部肿瘤协作组研究(E3486)
Leuk Lymphoma. 2003 Sep;44(9):1515-21. doi: 10.3109/10428190309178773.
10
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.大剂量阿糖胞苷和柔红霉素作为首次缓解期急性非淋巴细胞白血病巩固治疗的最新进展
Semin Oncol. 1987 Jun;14(2 Suppl 1):12-7.

引用本文的文献

1
Anthracycline antibiotics in cancer therapy. Focus on drug resistance.蒽环类抗生素在癌症治疗中的应用。聚焦于耐药性。
Drugs. 1994 Feb;47(2):223-58. doi: 10.2165/00003495-199447020-00002.
2
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.
Cancer Chemother Pharmacol. 1987;20(4):311-5. doi: 10.1007/BF00262582.
3
Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).输注速率无关的阿霉素细胞浓度及对人骨髓克隆形成细胞(CFU-GM)的细胞毒性。
Br J Cancer. 1987 Aug;56(2):123-6. doi: 10.1038/bjc.1987.168.
4
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.
Cancer Chemother Pharmacol. 1987;20(4):305-10. doi: 10.1007/BF00262581.
5
A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat.
Cancer Chemother Pharmacol. 1989;24(6):341-8. doi: 10.1007/BF00257439.
6
Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.成人急性髓细胞白血病的蒽环类药物分次治疗
Cancer Chemother Pharmacol. 1989;23(6):401-2. doi: 10.1007/BF00435846.